Clinical Trial Update: A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden

View source ↗

Summary

A completed clinical trial evaluated how much anticholinergic burden is attributable to medications used for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Snippet

Sponsor: Astellas Pharma Singapore Pte. Ltd. | Conditions: Overactive Bladder (OAB) | Status: COMPLETED